Background: The acceptability and efficacy of a new kit with a new formulation of quinine alkaloids designed for the intra-rectal administration in the treatment of non-per os malaria was assessed in the peripheral health care system of Mopti, Mali.

Methods: A single-arm trial was conducted from August 2003 to January 2004. An initial dose of diluted quinine alkaloids (20 mg/kg Quinimax) was administered by the intra-rectal route to children with presumptive non per-os malaria at six peripheral heath care centres. The children were then referred to two referral hospitals where standard inpatient care including intravenous route were routinely provided. A malaria thick smear was done at inclusion and a second malaria thick smear after arrival at the referral facility, where a more complete clinical examination and laboratory testing was done to confirm diagnosis. Confirmed cases of severe malaria or others diseases were treated according to national treatment guidelines. Cases of non per-os malaria received a second dose of intra rectal quinine alkaloids. Primary outcome was acceptability of the intra rectal route by children and their parents as well as the ease to handle the kit by health care workers.

Results: The study included 134 children with a median age of 33 months and 53.7% were male. Most of the children (67%) and 92% of parents or guardians readily accepted the intra-rectal route; 84% of health care workers found the kit easy to use. At the peripheral health care centres, 32% of children had a coma score < or = 3 and this was reduced to 10% at the referral hospital, following one dose of intra-rectal quinine alkaloids (IRQA). The mean time to availability of oral route treatment was 1.8 +/- 1.1 days. Overall, 73% of cases were confirmed severe malaria and for those the case fatality rate was 7.2%.

Conclusion: IRQA was well accepted by children, their parents/guardians and by the health workers at peripheral health facilities in Mopti, Mali. There was also a quick recovery from deep coma and a reduced case fatality rate in severe malaria.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904225PMC
http://dx.doi.org/10.1186/1475-2875-6-68DOI Listing

Publication Analysis

Top Keywords

quinine alkaloids
20
health care
20
peripheral health
16
severe malaria
12
malaria
9
acceptability efficacy
8
intra-rectal quinine
8
treatment non-per
8
non-per malaria
8
malaria peripheral
8

Similar Publications

In 1820 two French scientists - Pierre Joseph Pelletier and Jean Bienaimé Caventou - discovered and named the active alkaloid substance extracted from cinchona bark: quinine. The bark from the 'wondrous' fever tree, and its antimalarial properties, however, had long been known to both colonial scientists and indigenous Peruvians. From the mid-seventeenth century, cinchona bark, taken from trees that grow on the eastern slopes of the Andes, was part of a global circulation of botanical knowledge, practice and profit.

View Article and Find Full Text PDF
Article Synopsis
  • * Biological tests demonstrated that the extract can reduce venom-induced neuromuscular blockade when applied before exposure, but not after, suggesting timing is crucial for effectiveness.
  • * While quinine was not found in the extract, the presence of coumarin derivatives and other unknown alkaloids may contribute to the extract's ability to mitigate the effects of the venom.
View Article and Find Full Text PDF
Article Synopsis
  • * The study introduces Sensor-seq, a high-throughput platform that allows for the design and identification of aTF biosensors that can bind to a variety of non-native ligands, testing 17,737 variants of aTF TtgR against multiple compounds.
  • * Sensor-seq successfully finds biosensors with high performance for various ligands and showcases their practical use through cell-free detection systems for specific drugs, enhancing the ability to create new biosensors beyond natural limitations.
View Article and Find Full Text PDF

Biosynthetic Origin of the Methoxy Group in Quinine and Related Alkaloids.

Angew Chem Int Ed Engl

November 2024

Department of Natural Product Biosynthesis, Max Planck Institute for Chemical Ecology, Hans-Knöll-Straße 8, 07745, Jena, Germany.

Quinine is a historically important natural product containing a methoxy group that has been assumed to be incorporated at a late pathway stage. Here we show that the methoxy group in quinine and related alkaloids is introduced onto the starting substrate tryptamine. Feeding studies definitively show that 5-methoxytryptamine is utilized as a quinine biosynthetic intermediate in planta.

View Article and Find Full Text PDF

Distinct populations suppress or escalate intake of cocaine paired with aversive quinine.

Drug Alcohol Depend

December 2024

Department of Biological Sciences, University of Texas at El Paso,  500 W University Ave, El Paso, TX 79902, USA. Electronic address:

Background: Only a subset of individuals who encounter illicit drugs become persons with a substance use disorder. Individual differences in aversive reactions to drug-associated phenomena like smoke inhalation and unpleasant taste are predictors for continued use. While several preclinical studies have explored self-administration involving aversive cues, none have simultaneously introduced aversion with the initial drug self-administration.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!